AAAAAA

   
Results: 1-5 |
Results: 5
WHAT DOES TREATMENT OF DEPRESSION REALLY COST
Authors: CROGHAN TW OBENCHAIN RL CROWN WE
Citation: Tw. Croghan et al., WHAT DOES TREATMENT OF DEPRESSION REALLY COST, Health affairs, 17(4), 1998, pp. 198-208
TRICYCLIC ANTIDEPRESSANT AND SELECTIVE SEROTONIN REUPTAKE INHIBITORS ANTIDEPRESSANT SELECTION AND HEALTH-CARE COSTS IN THE NATURALISTIC SETTING - A MULTIVARIATE-ANALYSIS
Authors: HYLAN TR CROWN WH MENEADES L HEILIGENSTEIN JH MELFI CA CROGHAN TW BUESCHING DP
Citation: Tr. Hylan et al., TRICYCLIC ANTIDEPRESSANT AND SELECTIVE SEROTONIN REUPTAKE INHIBITORS ANTIDEPRESSANT SELECTION AND HEALTH-CARE COSTS IN THE NATURALISTIC SETTING - A MULTIVARIATE-ANALYSIS, Journal of affective disorders, 47(1-3), 1998, pp. 71-79
ECONOMIC CONSEQUENCES OF SELECTIVE SEROTONIN REUPTAKE INHIBITOR USE WITH DRUGS ALSO METABOLIZED BY THE CYTOCHROME-P-450 SYSTEM
Authors: OZMINKOWSKI RJ HYLAN TR MELFI CA MENEADES LM CROWN WH CROGHAN TW ROBINSON RL
Citation: Rj. Ozminkowski et al., ECONOMIC CONSEQUENCES OF SELECTIVE SEROTONIN REUPTAKE INHIBITOR USE WITH DRUGS ALSO METABOLIZED BY THE CYTOCHROME-P-450 SYSTEM, Clinical therapeutics, 20(4), 1998, pp. 780-796
BOOTSTRAP ANALYSES OF COST-EFFECTIVENESS IN ANTIDEPRESSANT PHARMACOTHERAPY
Authors: OBENCHAIN RL MELFI CA CROGHAN TW BUESCHING DP
Citation: Rl. Obenchain et al., BOOTSTRAP ANALYSES OF COST-EFFECTIVENESS IN ANTIDEPRESSANT PHARMACOTHERAPY, PharmacoEconomics, 11(5), 1997, pp. 464-472
EFFECT OF ANTIDEPRESSANT THERAPY ON HEALTH-CARE UTILIZATION AND COSTSIN PRIMARY-CARE
Authors: CROGHAN TW LAIR TJ ENGELHART L CROWN WE COPLEYMERRIMAN C MELFI CA OBENCHAIN RL BUESCHING DP
Citation: Tw. Croghan et al., EFFECT OF ANTIDEPRESSANT THERAPY ON HEALTH-CARE UTILIZATION AND COSTSIN PRIMARY-CARE, Psychiatric services, 48(11), 1997, pp. 1420-1426
Risultati: 1-5 |